RIGL
Rigel Pharmaceuticals

12,353
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
After Hours

Estimated EPS

$0.90

Estimated Rev

$61.88M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$0.90
--
--
N/A
Q2 '25
$2.58
$3.28
27.13%
BEAT
Q1 '25
$0.09
$0.63
605.80%
BEAT
Q4 '24
$0.45
$0.80
77.48%
BEAT
Q3 '24
$0.06
$0.70
1097.07%
BEAT

Latest RIGL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.